The Kenyan government is taking steps to strengthen its pharmaceutical regulation, product traceability, and supply-chain oversight to ensure patients have access to safe, effective, and quality-assured medicines. This move aims to build and maintain patient trust in the healthcare system. According to Dr. John Munyu, Chairperson of the Pharmacy and Poisons Board, patients should receive medicines with confidence that they have been properly assessed, safely stored, and supplied through legitimate channels.
Dr. Munyu made these remarks at the 6th PharmaReg & MedDevReg AfriSummit 2026 in Nairobi, which was presided over by Cabinet Secretary for Health Aden Duale. The summit brought together national regulatory authorities, health leaders, and stakeholders from Africa and beyond to exchange knowledge and develop partnerships that support practical regulatory action. Dr. Munyu emphasized that strong regulatory systems are essential to building and maintaining patient trust.
Kenya has strengthened its laws, technical capacity, quality systems, and regulatory processes, with a focus on making regulatory decisions consistent, predictable, and risk-based. The country has also made progress through the World Health Organization Global Benchmarking Tool, which has helped sharpen the focus on how the regulatory system performs in practice. This progress has enabled Kenya to improve its regulatory framework and ensure that health products meet international standards.
The Pharmacy and Poisons Board has implemented the renewal of marketing authorisations to ensure health products remain under regulatory scrutiny beyond their initial approval. The board has also strengthened inspections of manufacturers, wholesalers, and other premises to protect product quality throughout the supply chain. These measures aim to prevent the distribution of substandard or falsified medical products.
Dr. Munyu stated that the Board is strengthening pharmacy practice standards and advancing product authentication and traceability. These measures will enable regulators to track health products across the supply chain and respond quickly when safety or quality concerns are detected. The Board is also expanding the use of regulatory reliance, allowing assessments and inspection outcomes from trusted regulatory authorities to inform national regulatory decisions.
Dr. Munyu called for stronger collaboration among African regulatory authorities, noting that regulatory maturity, reliance, local manufacturing, digital systems, and supply-chain security cannot be addressed by one institution or country working alone. The summit provided a platform for stakeholders to discuss these issues and develop partnerships to support practical regulatory action. The event was attended by Principal Secretary for Medical Services Dr. Ouma Oluga, Pharmacy and Poisons Board Chief Executive Officer Dr. Ahmed Mohamed, and delegates from across the continent.
The Kenyan government's efforts to strengthen medicine regulation aim to ensure that patients receive high-quality medicines that meet international standards. The country's progress in regulatory maturity and reliance is expected to enhance patient trust and confidence in the healthcare system. Key stakeholders, including regulatory authorities and healthcare professionals, will continue to work together to address the challenges facing the pharmaceutical sector and ensure that patients receive safe and effective medicines.
Key points
- Strengthening pharmaceutical regulation to ensure safe and effective medicines
- Improving product traceability and supply-chain oversight
- Enhancing collaboration among African regulatory authorities
